The Safety and Efficacy of Thermal Ablation Combined With Apatinib and Carilimub for Advanced Liver Cancer
Status:
Recruiting
Trial end date:
2023-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to evaluate the efficacy and safety of simple local ablation,
local ablation combined with apatinib, local ablation combined with apatinib and PD-1
antibody SHR-1210 for the treatment of advanced liver cancer.